Rukhshana Dina Rabbani

Papers

Total Citations

H-Index

About

Rukhshana Dina Rabbani is a rising authority in the field of oncologic obstetrics, with a focused expertise in the rare and challenging intersection of cancer and pregnancy. Her most-cited work, "Gestational Renal Cell Cancer – An Update" (2023), has already garnered 6 citations, highlighting its critical role in addressing a significant clinical gap. In this seminal paper, Rabbani elucidates the diagnostic and management complexities of gestational renal cell carcinoma (RCC), a condition whose symptoms often masquerade as normal pregnancy changes. Her major contribution lies in providing a clear, evidence-based framework for identifying this rare malignancy, thereby reducing diagnostic delays and improving maternal-fetal outcomes. By systematically outlining the clinical challenges and updated management strategies, Rabbani’s work serves as an essential guide for oncologists and obstetricians navigating these treacherous waters. Her research not only advances the understanding of gestational RCC but also underscores the broader need for vigilance in pregnancy-associated cancers. As her citation count grows, Rabbani is establishing herself as a key voice in this niche, with her work promising to shape future clinical protocols and inspire further investigation into cancer biology during gestation.